本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Adverum Biotechnologies, Inc.

2.26
+0.05002.26%
盤後2.260.00000.00%19:30 EDT
成交量:7.65萬
成交額:17.35萬
市值:4,721.31萬
市盈率:-0.31
高:2.33
開:2.23
低:2.21
收:2.21
資料載入中...
2023/03/30

重要事件披露

8-K - Current report
2023/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/13

重要事件披露

8-K - Current report
2022/11/25

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/06

重要事件披露

8-K - Current report
2022/06/16

重要事件披露

8-K - Current report
2022/06/06

重要事件披露

8-K - Current report